Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership1,433,471 shares
Latest Disclosed Value $ 11,654,119
Goldman Sachs Group Inc ownership in KUR / Kura Oncology, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 1,433,471 shares of Kura Oncology, Inc. (DE:KUR) valued at $9,532,582 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,837,264 shares of Kura Oncology, Inc.. This represents a change in shares of -21.98% during the quarter. The current value of the position is $10,837,041 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (KUR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:KUR / Kura Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY CMN 50127T109 1,433,471 -403,793 -21.98 11,654 -38.95 0.0003
2026-02-10 2025-12-31 13F KURA ONCOLOGY CMN 50127T109 1,837,264 -777,462 -29.73 19,089 -17.51 0.0024
2025-11-14 2025-09-30 13F KURA ONCOLOGY CMN 50127T109 2,614,726 1,681,056 180.05 23,140 329.55 0.0028
2025-08-14 2025-06-30 13F KURA ONCOLOGY CMN 50127T109 933,670 104,889 12.66 5,387 -1.50 0.0007
2025-06-27 2025-03-31 13F/A-2 KURA ONCOLOGY CMN 50127T109 828,781 -34,304 -3.97 5,470 -27.24 0.0009
2025-05-16 2025-03-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 828,781 -34,304 5,470 0.0009
2025-05-09 2025-03-31 13F KURA ONCOLOGY CMN 50127T109 828,781 -34,304 5,470 0.0002
2025-02-11 2024-12-31 13F KURA ONCOLOGY CMN 50127T109 863,085 153,601 21.65 7,517 -45.78 0.0012
2024-11-14 2024-09-30 13F KURA ONCOLOGY CMN 50127T109 709,484 -122,401 -14.71 13,863 -19.06 0.0022
2024-08-13 2024-06-30 13F KURA ONCOLOGY CMN 50127T109 831,885 46,009 5.85 17,129 2.18 0.0029
2024-05-15 2024-03-31 13F KURA ONCOLOGY CMN 50127T109 785,876 254,314 47.84 16,763 119.31 0.0030
2024-05-14 2023-12-31 13F/A-2 KURA ONCOLOGY CMN 50127T109 531,562 70,765 15.36 7,644 81.89 0.0014
2024-03-01 2023-12-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 531,562 70,765 7,644 0.0004
2024-02-13 2023-12-31 13F KURA ONCOLOGY CMN 50127T109 531,562 70,765 7,644 0.0004
2024-05-15 2023-09-30 13F/A-1 KURA ONCOLOGY CMN 50127T109 460,797 -469,561 -50.47 4,202 -57.31 0.0009
2023-11-14 2023-09-30 13F KURA ONCOLOGY CMN 50127T109 460,797 -469,561 4,202 0.0008
2024-05-14 2023-06-30 13F/A-1 KURA ONCOLOGY CMN 50127T109 930,358 -156,442 -14.39 9,843 -25.94 0.0021
2023-08-15 2023-06-30 13F KURA ONCOLOGY CMN 50127T109 930,358 -156,442 9,843 0.0020
2024-05-14 2023-03-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 1,086,800 -60,691 -5.29 13,292 -6.66 0.0031
2023-05-11 2023-03-31 13F KURA ONCOLOGY CMN 50127T109 1,086,800 -60,691 13,292 0.0028
2024-05-14 2022-12-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 1,147,491 -288,301 -20.08 14,240 74,847.37 0.0035
2023-02-13 2022-12-31 13F KURA ONCOLOGY CMN 50127T109 1,147,491 -288,301 14,240 0.0032
2024-05-14 2022-09-30 13F/A-1 KURA ONCOLOGY CMN 50127T109 1,435,792 470,766 48.78 20 11.76 0.0050
2022-11-14 2022-09-30 13F KURA ONCOLOGY CMN 50127T109 1,435,792 470,766 19,613 0.0045
2024-05-14 2022-06-30 13F/A-2 KURA ONCOLOGY CMN 50127T109 965,026 483,836 100.55 18 -99.78 0.0044
2022-08-18 2022-06-30 13F/A-1 KURA ONCOLOGY CMN 50127T109 965,026 483,836 17,689 0.0040
2022-08-15 2022-06-30 13F KURA ONCOLOGY CMN 50127T109 965,026 483,836 17,689 0.0040
2022-05-16 2022-03-31 13F KURA ONCOLOGY CMN 50127T109 481,190 174,913 57.11 7,738 80.46 0.0016
2022-02-17 2021-12-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 306,277 24,560 8.72 4,288 -18.73 0.0009
2022-02-14 2021-12-31 13F KURA ONCOLOGY CMN 50127T109 306,277 24,560 4,288 0.0002
2022-01-20 2021-09-30 13F/A-1 KURA ONCOLOGY CMN 50127T109 281,717 111,374 65.38 5,276 48.54 0.0011
2021-11-10 2021-09-30 13F KURA ONCOLOGY CMN 50127T109 281,717 111,374 5,276 0.0003
2021-08-13 2021-06-30 13F KURA ONCOLOGY CMN 50127T109 170,343 -873,665 -83.68 3,552 -87.97 0.0008
2021-05-17 2021-03-31 13F KURA ONCOLOGY CMN 50127T109 1,044,008 -211,289 -16.83 29,514 -28.01 0.0074
2021-02-12 2020-12-31 13F KURA ONCOLOGY CMN 50127T109 1,255,297 651,001 107.73 40,998 121.42 0.0105
2020-11-13 2020-09-30 13F KURA ONCOLOGY CMN 50127T109 604,296 -27,416 -4.34 18,516 79.84 0.0053
2020-08-12 2020-06-30 13F KURA ONCOLOGY CMN 50127T109 631,712 535,271 555.02 10,296 972.50 0.0031
2020-05-15 2020-03-31 13F KURA ONCOLOGY CMN 50127T109 96,441 -557,411 -85.25 960 -89.32 0.0003
2020-02-14 2019-12-31 13F KURA ONCOLOGY CMN 50127T109 653,852 437,182 201.77 8,991 173.53 0.0023
2019-11-14 2019-09-30 13F KURA ONCOLOGY CMN 50127T109 216,670 -1,077 -0.49 3,287 -23.34 0.0009
2019-08-14 2019-06-30 13F KURA ONCOLOGY CMN 50127T109 217,747 -423,484 -66.04 4,288 -59.69 0.0012
2019-05-15 2019-03-31 13F KURA ONCOLOGY CMN 50127T109 641,231 621,082 3,082.45 10,638 3,659.01 0.0032
2019-02-14 2018-12-31 13F KURA ONCOLOGY CMN 50127T109 20,149 -16,277 -44.69 283 -55.57 0.0001
2018-11-14 2018-09-30 13F KURA ONCOLOGY CMN 50127T109 36,426 -577 -1.56 637 -5.35 0.0002
2018-08-14 2018-06-30 13F KURA ONCOLOGY CMN 50127T109 37,003 8,900 31.67 673 27.70 0.0002
2018-05-15 2018-03-31 13F KURA ONCOLOGY CMN 50127T109 28,103 -1,119 -3.83 527 17.90 0.0001
2018-02-14 2017-12-31 13F KURA ONCOLOGY CMN 50127T109 29,222 9,590 48.85 447 52.56 0.0001
2017-11-14 2017-09-30 13F KURA ONCOLOGY CMN 50127T109 19,632 19,632 293 0.0001
2017-08-14 2017-06-30 13F KURA ONCOLOGY CMN 50127T109 0 -60,530 -100.00 0 -100.00
2017-05-18 2017-03-31 13F/A-1 KURA ONCOLOGY CMN 50127T109 60,530 36,730 154.33 533 732.81 0.0001
2017-05-15 2017-03-31 13F KURA ONCOLOGY CMN 50127T109 60,530 533
2016-08-15 2016-06-30 13F KURA ONCOLOGY CMN 50127T109 23,800 11,019 86.21 64 23.08 0.0000
2016-05-13 2016-03-31 13F KURA ONCOLOGY CMN 50127T109 12,781 12,781 52 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-14 2021-03-31 13F KURA ONCOLOGY CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F KURA ONCOLOGY CMN Call 70,000 2,286 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.